TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma is a research paper published in Science Advances (2023). On theSindex it has a DataRank of 0. It has been cited 114 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NINDS NIH HHS
Grant: R01 NS106612
NCI NIH HHS
Grant: P30 CA091842
NINDS NIH HHS
Grant: R25 NS090978
National Institutes of Health
Grant: 5R01NS106612-05
NAD+ Pathway Signaling in Glioblastoma Tumor Growth and Therapy Resistance
FWCI
10.95
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals